| Authors: |
Soussi T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, UMRS_938 Hematopoietic and Leukemic Development, Paris, France., Kundu S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Gerbaud P; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, UMRS_938 Hematopoietic and Leukemic Development, Paris, France., Pandzic T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Baskin B; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ladenvall C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Delhommeau F; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, UMRS_938 Hematopoietic and Leukemic Development, Paris, France., Sjöblom T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. |
